Cargando…

Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease

BACKGROUND/AIMS: The Crohn’s and Colitis Knowledge (CCKNOW) score does not reflect updated knowledge relating to inflammatory bowel disease (IBD). The aim of this study was to develop, validate, and apply a novel tool to measure disease-related knowledge in IBD patients. METHODS: A questionnaire com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Hyuk, Yang, Suk-Kyun, So, Hoonsub, Lee, Ko Eun, Park, Sang Hyoung, Jung, Sung-Ae, Choh, Joong Haeng, Shin, Cheol Min, Park, Young Soo, Kim, Nayoung, Lee, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325432/ https://www.ncbi.nlm.nih.gov/pubmed/29172400 http://dx.doi.org/10.3904/kjim.2017.104

Ejemplares similares

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease
por: Park, Jihye, et al.
Publicado: (2020)

Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn’s disease
por: Park, Jin, et al.
Publicado: (2023)

Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study
por: Park, Jihye, et al.
Publicado: (2022)

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease
por: Jun, Jae Chang, et al.
Publicado: (2019)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
por: Lee, Ko Eun, et al.
Publicado: (2019)

Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls
por: Heo, Min, et al.
Publicado: (2023)

Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease
por: Han, Yoo Min, et al.
Publicado: (2017)

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease
por: Hong, Seung Wook, et al.
Publicado: (2021)

Sex difference in bowel preparation quality and colonoscopy time
por: Hwang, Young-Jae, et al.
Publicado: (2021)

Insufficient Knowledge of Korean Gastroenterologists Regarding the Vaccination of Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022)

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Yoon, Hyuk, et al.
Publicado: (2015)

10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
por: Koo, Hee Moon, et al.
Publicado: (2023)

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases
por: Ryu, Han Hee, et al.
Publicado: (2021)

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015)

Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?
por: Hwang, Jae Jin, et al.
Publicado: (2015)

Patient Descriptions of Rectal Effluents May Help to Predict the Quality of Bowel Preparation With Photographic Examples
por: So, Hoonsub, et al.
Publicado: (2015)

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study
por: Shin, Dong Woo, et al.
Publicado: (2018)

Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients
por: Cha, Jae Myung, et al.
Publicado: (2017)

The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity
por: Kim, Seong Kyun, et al.
Publicado: (2021)

Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients
por: Lee, Sun Min, et al.
Publicado: (2021)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
por: Cho, Jae Ho, et al.
Publicado: (2020)

Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men
por: Choi, Yoon Jin, et al.
Publicado: (2018)

Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease
por: Yang, Kwan Mo, et al.
Publicado: (2017)

Risk of Heart Disease after Cholecystectomy: A Nationwide Population-Based Cohort Study in South Korea
por: Kim, Yoo Jin, et al.
Publicado: (2021)

Diffusion-Weighted MR Enterography to Monitor Bowel Inflammation after Medical Therapy in Crohn's Disease: A Prospective Longitudinal Study
por: Huh, Jimi, et al.
Publicado: (2017)

Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
por: Kim, Young Sun, et al.
Publicado: (2017)

The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022)

A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study
por: Lee, Chang Kyun, et al.
Publicado: (2019)

Clinical features and outcomes in spontaneous intramural small bowel hematoma: cohort study and literature review
por: Kang, Eun Ae, et al.
Publicado: (2019)

Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms
por: Yoon, Hyuk, et al.
Publicado: (2022)

Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
por: Yoon, Hyuk, et al.
Publicado: (2022)

CT Enterography for Surveillance of Anastomotic Recurrence within 12 Months of Bowel Resection in Patients with Crohn's Disease: An Observational Study Using an 8-Year Registry
por: Choi, In Young, et al.
Publicado: (2017)

Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis
por: Lee, Chang Min, et al.
Publicado: (2016)

Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data
por: Ah Lee, Hyeon, et al.
Publicado: (2015)

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
por: Lee, Chan Hyung, et al.
Publicado: (2020)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_13t520l117i2tljo53amg5lp15